Airway reactivity in children before and after stem cell transplantation

Lea Bentur1, Moshe Lapidot, Galit Livnat

  • 1Pediatric Pulmonary Unit, Meyer Children's Hospital of Haifa, Rambam Medical Center, Haifa, Israel. l_bentur@rambam.health.gov.il

Pediatric Pulmonology
|August 12, 2009
PubMed

Insights

Stem cell transplantation (SCT) can increase airway hyper-reactivity (AHR) in children, as shown by methacholine challenge tests (MCT). This increased AHR post-SCT is linked to a higher risk of pulmonary complications and hospitalizations.

Area of Science:

  • Pediatric Hematology-Oncology
  • Pulmonology
  • Stem Cell Transplantation Research

Background:

  • Stem cell transplantation (SCT) is a critical treatment for various pediatric hematological and oncological conditions.
  • Pulmonary complications are a known risk following SCT, impacting patient recovery and long-term health.
  • The potential for developing airway hyper-reactivity (AHR) post-SCT has not been extensively studied in pediatric populations.

Purpose of the Study:

  • To investigate the incidence of increased airway hyper-reactivity (AHR) after SCT in pediatric patients.
  • To assess the correlation between post-SCT AHR and the occurrence of pulmonary complications.
  • To evaluate changes in airway obstruction using methacholine challenge tests (MCT) before and after SCT.

Main Methods:

  • A prospective study involving pediatric patients undergoing SCT.
  • Pulmonary function tests and methacholine challenge tests (MCT) were performed pre- and post-SCT.
  • Systematic assessment and recording of all pulmonary complications and hospitalizations.

Main Results:

  • A significant decrease in mean PC(20) values (indicating increased AHR) was observed post-SCT (P=0.018).
  • The prevalence of AHR increased from 2/21 patients pre-SCT to 8/21 patients post-SCT (P=0.043).
  • Patients with post-SCT AHR experienced a higher rate of pulmonary complications (62.5% vs 15.4%, P=0.041) and hospitalizations (median 1 vs 0, P=0.045).

Conclusions:

  • Increased airway reactivity is a notable finding following pediatric SCT.
  • Post-transplant AHR, identified via MCT, may serve as a predictive marker for pulmonary complications.
  • Further research is warranted to elucidate the mechanisms behind AHR post-SCT and its clinical significance.